436 related articles for article (PubMed ID: 33529176)
1. Macrophage AXL receptor tyrosine kinase inflames the heart after reperfused myocardial infarction.
DeBerge M; Glinton K; Subramanian M; Wilsbacher LD; Rothlin CV; Tabas I; Thorp EB
J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33529176
[TBL] [Abstract][Full Text] [Related]
2. MerTK Cleavage on Resident Cardiac Macrophages Compromises Repair After Myocardial Ischemia Reperfusion Injury.
DeBerge M; Yeap XY; Dehn S; Zhang S; Grigoryeva L; Misener S; Procissi D; Zhou X; Lee DC; Muller WA; Luo X; Rothlin C; Tabas I; Thorp EB
Circ Res; 2017 Sep; 121(8):930-940. PubMed ID: 28851810
[TBL] [Abstract][Full Text] [Related]
3. Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction.
Wan E; Yeap XY; Dehn S; Terry R; Novak M; Zhang S; Iwata S; Han X; Homma S; Drosatos K; Lomasney J; Engman DM; Miller SD; Vaughan DE; Morrow JP; Kishore R; Thorp EB
Circ Res; 2013 Sep; 113(8):1004-12. PubMed ID: 23836795
[TBL] [Abstract][Full Text] [Related]
4. Axl and Mertk Receptors Cooperate to Promote Breast Cancer Progression by Combined Oncogenic Signaling and Evasion of Host Antitumor Immunity.
Davra V; Kumar S; Geng K; Calianese D; Mehta D; Gadiyar V; Kasikara C; Lahey KC; Chang YJ; Wichroski M; Gao C; De Lorenzo MS; Kotenko SV; Bergsbaken T; Mishra PK; Gause WC; Quigley M; Spires TE; Birge RB
Cancer Res; 2021 Feb; 81(3):698-712. PubMed ID: 33239426
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of lung homeostasis and silicosis by the TAM receptors MerTk and Axl.
Guimarães-Pinto K; Leandro M; Corrêa A; Maia EP; Rodrigues L; da Costa ALA; Rafael Machado Ferreira J; Claudio-Etienne E; Siebenlist U; He J; Rigoni TDS; Ferreira TPT; Jannini-Sa YAP; Matos-Guedes HL; Costa-da-Silva AC; Lopes MF; Silva PMR; Kelsall BL; Filardy AA
Front Immunol; 2024; 15():1380628. PubMed ID: 38774866
[TBL] [Abstract][Full Text] [Related]
6. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M
Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560
[TBL] [Abstract][Full Text] [Related]
7. Tyro3, Axl, and Mertk receptors differentially participate in platelet activation and thrombus formation.
Zhou J; Yang A; Wang Y; Chen F; Zhao Z; Davra V; Suzuki-Inoue K; Ozaki Y; Birge RB; Lu Q; Wu Y
Cell Commun Signal; 2018 Dec; 16(1):98. PubMed ID: 30541554
[TBL] [Abstract][Full Text] [Related]
8. Autophagy induced by AXL receptor tyrosine kinase alleviates acute liver injury via inhibition of NLRP3 inflammasome activation in mice.
Han J; Bae J; Choi CY; Choi SP; Kang HS; Jo EK; Park J; Lee YS; Moon HS; Park CG; Lee MS; Chun T
Autophagy; 2016 Dec; 12(12):2326-2343. PubMed ID: 27780404
[TBL] [Abstract][Full Text] [Related]
9. Tyro3/Axl/Mertk-deficient mice develop bone marrow edema which is an early pathological marker in rheumatoid arthritis.
Waterborg CEJ; Koenders MI; van Lent PLEM; van der Kraan PM; van de Loo FAJ
PLoS One; 2018; 13(10):e0205902. PubMed ID: 30335822
[TBL] [Abstract][Full Text] [Related]
10. Myeloid-Epithelial-Reproductive Receptor Tyrosine Kinase and Milk Fat Globule Epidermal Growth Factor 8 Coordinately Improve Remodeling After Myocardial Infarction via Local Delivery of Vascular Endothelial Growth Factor.
Howangyin KY; Zlatanova I; Pinto C; Ngkelo A; Cochain C; Rouanet M; Vilar J; Lemitre M; Stockmann C; Fleischmann BK; Mallat Z; Silvestre JS
Circulation; 2016 Mar; 133(9):826-39. PubMed ID: 26819373
[TBL] [Abstract][Full Text] [Related]
11. Receptor tyrosine kinases Tyro3, Axl, and Mertk differentially contribute to antibody-induced arthritis.
Gao L; He C; Yang A; Zhou H; Lu Q; Birge RB; Wu Y
Cell Commun Signal; 2023 Aug; 21(1):195. PubMed ID: 37537628
[TBL] [Abstract][Full Text] [Related]
12. TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in Melanoma.
Holtzhausen A; Harris W; Ubil E; Hunter DM; Zhao J; Zhang Y; Zhang D; Liu Q; Wang X; Graham DK; Frye SV; Earp HS
Cancer Immunol Res; 2019 Oct; 7(10):1672-1686. PubMed ID: 31451482
[TBL] [Abstract][Full Text] [Related]
13. Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment.
Myers KV; Amend SR; Pienta KJ
Mol Cancer; 2019 May; 18(1):94. PubMed ID: 31088471
[TBL] [Abstract][Full Text] [Related]
14. Targeted degradation of MERTK and other TAM receptor paralogs by heterobifunctional targeted protein degraders.
Gadiyar V; Patel G; Chen J; Vigil D; Ji N; Campbell V; Sharma K; Shi Y; Weiss MM; Birge RB; Davra V
Front Immunol; 2023; 14():1135373. PubMed ID: 37545504
[TBL] [Abstract][Full Text] [Related]
15. The small-molecule MERTK inhibitor UNC2025 decreases platelet activation and prevents thrombosis.
Branchford BR; Stalker TJ; Law L; Acevedo G; Sather S; Brzezinski C; Wilson KM; Minson K; Lee-Sherick AB; Davizon-Castillo P; Ng C; Zhang W; Neeves KB; Lentz SR; Wang X; Frye SV; Shelton Earp H; DeRyckere D; Brass LF; Graham DK; Di Paola JA
J Thromb Haemost; 2018 Feb; 16(2):352-363. PubMed ID: 29045015
[TBL] [Abstract][Full Text] [Related]
16. Axl and MerTK regulate synovial inflammation and are modulated by IL-6 inhibition in rheumatoid arthritis.
Nerviani A; Boutet MA; Ghirardi GM; Goldmann K; Sciacca E; Rivellese F; Pontarini E; Prediletto E; Abatecola F; Caliste M; Pagani S; Mauro D; Bellan M; Cubuk C; Lau R; Church SE; Hudson BM; Humby F; Bombardieri M; Lewis MJ; Pitzalis C
Nat Commun; 2024 Mar; 15(1):2398. PubMed ID: 38493215
[TBL] [Abstract][Full Text] [Related]
17. Axl and MerTK receptor tyrosine kinases maintain human macrophage efferocytic capacity in the presence of viral triggers.
Grabiec AM; Goenka A; Fife ME; Fujimori T; Hussell T
Eur J Immunol; 2018 May; 48(5):855-860. PubMed ID: 29400409
[TBL] [Abstract][Full Text] [Related]
18. Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities.
Lew ED; Oh J; Burrola PG; Lax I; Zagórska A; Través PG; Schlessinger J; Lemke G
Elife; 2014 Sep; 3():. PubMed ID: 25265470
[TBL] [Abstract][Full Text] [Related]
19. MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents.
McDaniel NK; Cummings CT; Iida M; Hülse J; Pearson HE; Vasileiadi E; Parker RE; Orbuch RA; Ondracek OJ; Welke NB; Kang GH; Davies KD; Wang X; Frye SV; Earp HS; Harari PM; Kimple RJ; DeRyckere D; Graham DK; Wheeler DL
Mol Cancer Ther; 2018 Nov; 17(11):2297-2308. PubMed ID: 30093568
[TBL] [Abstract][Full Text] [Related]
20. MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation.
Cai B; Thorp EB; Doran AC; Subramanian M; Sansbury BE; Lin CS; Spite M; Fredman G; Tabas I
Proc Natl Acad Sci U S A; 2016 Jun; 113(23):6526-31. PubMed ID: 27199481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
